Literature DB >> 9308939

Bladder movement during radiation therapy for bladder cancer: implications for treatment planning.

S L Turner1, R Swindell, N Bowl, J Marrs, B Brookes, G Read, R A Cowan.   

Abstract

PURPOSE: To describe and quantify bladder movement during radical radiation therapy (RT). To attempt to identify factors that predict for excessive alterations in bladder position. To use the above information to assist in defining the "adequate" planning target volume margin. METHODS AND MATERIALS: Thirty patients with bladder cancer suitable for radical courses of RT were followed prospectively. Patients had an initial planning computerized tomography (CT) scan of the pelvis and three subsequent scans performed weekly during the treatment period. The following measurements were made on each scan in the midbladder slice: maximum anteroposterior (AP) and lateral bladder dimensions, AP rectal diameter, and the distance (margin) between the bladder walls (anterior, posterior, right, and left lateral) and the 95% isodose line. Various patient and tumor data, including bladder and bowel symptoms, were recorded to attempt correlation with bladder movement.
RESULTS: Bladder size: the median bladder size (area) over all scans in all patients was 36.9 cm2 (range: 16.2 to 80.9 cm2). The change in bladder area across each sequence varied from 3.3 to 29.1 cm2 (7-55% change in area between scans). Patients with bladders of larger than the median size on the planning scan (despite emptying) were more likely to have alteration in size than those with small bladders, and this change was in the direction of contraction (p = 0.01). Bladder displacement: bladder wall movement of > 1.5 cm was defined as "significant." Eighteen of 30 patients (60%) demonstrated "significant" movement of at least one bladder wall relative to the original isodose plot. Movement resulting in margin reduction occurred in 10 patients (33%). Two patients required treatment replanning due to consistently altered bladder position. There was no pattern to displacement through RT, and all walls were at approximately equal risk of movement. Factors influencing bladder movement: posterior bladder wall movement appeared to relate to "marked" (>2 cm) rectal diameter change. There was a trend for patients with larger amounts of residual bladder tumor (greater than the median) to exhibit more bladder movement; 11 of 14 "moved" compared with 7 of 16 patients with less residual tumor. Other clinical factors including age, sex, body size, acute RT reaction, and tumor stage did not appear to relate to bladder movement.
CONCLUSION: Bladder movement during RT is clinically relevant and is random with respect to both time and direction. We recommend, at least with respect to tumor-bearing regions of the bladder, that no less than a 2.0 cm margin should be allowed.

Entities:  

Mesh:

Year:  1997        PMID: 9308939     DOI: 10.1016/s0360-3016(97)00070-9

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  13 in total

Review 1.  Radiation dose-volume effects of the urinary bladder.

Authors:  Akila N Viswanathan; Ellen D Yorke; Lawrence B Marks; Patricia J Eifel; William U Shipley
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

Review 2.  Image-guided radiation therapy for muscle-invasive bladder cancer.

Authors:  Juliette Thariat; Shafak Aluwini; Qiong Pan; Mickael Caullery; Pierre-Yves Marcy; Martin Housset; Jean-Leon Lagrange
Journal:  Nat Rev Urol       Date:  2011-11-08       Impact factor: 14.432

3.  The observed variance between predicted and measured radiation dose in breast and prostate patients utilizing an in vivo dosimeter.

Authors:  Charles W Scarantino; Bradley R Prestidge; Mitchel S Anscher; Carolyn R Ferree; William T Kearns; Robert D Black; Natasha G Bolick; Gloria P Beyer
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-10-01       Impact factor: 7.038

Review 4.  New approaches in the use of radiation therapy in the treatment of infiltrative transitional-cell cancer of the bladder.

Authors:  P Warde; M K Gospodarowicz
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

5.  Analysis of inter- and intra fractional partial bladder wall movement using implanted fiducial markers.

Authors:  Kentaro Nishioka; Shinichi Shimizu; Nobuo Shinohara; Yoichi M Ito; Takashige Abe; Satoru Maruyama; Norio Katoh; Rumiko Kinoshita; Takayuki Hashimoto; Naoki Miyamoto; Rikiya Onimaru; Hiroki Shirato
Journal:  Radiat Oncol       Date:  2017-03-01       Impact factor: 3.481

6.  BioXmark® liquid fiducial markers for image-guided radiotherapy in muscle invasive bladder cancer: a safety and performance trial.

Authors:  Mischa de Ridder; Lara C Gerbrandy; Theo M de Reijke; Karel A Hinnen; Maarten C C M Hulshof
Journal:  Br J Radiol       Date:  2020-06-01       Impact factor: 3.039

7.  Introduction of online adaptive radiotherapy for bladder cancer through a multicentre clinical trial (Trans-Tasman Radiation Oncology Group 10.01): Lessons learned.

Authors:  Daniel Pham; Paul Roxby; Tomas Kron; Aldo Rolfo; Farshad Foroudi
Journal:  J Med Phys       Date:  2013-04

8.  Evaluation of inter-observer variability of bladder boundary delineation on cone-beam CT.

Authors:  Kentaro Nishioka; Shinichi Shimizu; Rumiko Kinoshita; Tetsuya Inoue; Shunsuke Onodera; Koichi Yasuda; Keiichi Harada; Yukiko Nishikawa; Rikiya Onimaru; Hiroki Shirato
Journal:  Radiat Oncol       Date:  2013-07-23       Impact factor: 3.481

9.  Prospective phase II study of image-guided local boost using a real-time tumor-tracking radiotherapy (RTRT) system for locally advanced bladder cancer.

Authors:  Kentaro Nishioka; Shinichi Shimizu; Nobuo Shinohara; Yoichi M Ito; Takashige Abe; Satoru Maruyama; Rumiko Kinoshita; Keiichi Harada; Noboru Nishikawa; Naoki Miyamoto; Rikiya Onimaru; Hiroki Shirato
Journal:  Jpn J Clin Oncol       Date:  2013-12-02       Impact factor: 3.019

10.  Targeting the Tumor: Assessing the Impact of Bladder Volume and Position on Accuracy of Radiation Delivery for Patients with Bladder Cancer.

Authors:  Andrew Kochan; Ryan Rivest; Katie Galloway; Pascal Lambert; Aldrich Ong; Rashmi Koul; Shahida Ahmed; Bashir Bashir; Harvey Quon
Journal:  Cureus       Date:  2017-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.